Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Ashrafsons Pharmaceutical products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Swabi · Pakistan

Swabi-based pharmaceutical manufacturer with sterile liquid injectable and infusion manufacturing capabilities.

Ashrafsons Pharmaceutical products in Pakistan

Ashrafsons Pharmaceutical (Pvt) Ltd has 24 medicine presentations registered in Pakistan under 22 brands, covering 8 generic medicines. Most of its products are in Fluids & supportive care and Anti-infectives. Its brands with the most registered strengths and packs are Jectsol-5 100ml (Dextrose + Sodium chloride), Jectsol-NS 100ml (Sodium chloride), Jectmet 100ml (Metronidazole) and Jectsol (Mannitol). 24 products have an official DRAP price on MedInfoBase. See all 22 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation11 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check12 Oct 2026Latest source-check date across this published portfolio
Latest effective price date28 Sep 2026Newest effective date among published current price records
Corporate profile evidence1 sourceCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Ashrafsons Pharmaceuticals (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
Plot No. 40, Road R-2, Industrial Estate, Gadoon Amazai, Swabi, Khyber Pakhtunkhwa, Pakistan
Corporate source details checked
16 Aug 2026
Corporate profile completeness
50%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000947 Ashrafsons Pharmaceuticals (Pvt) Ltd. · Khyber Pakhtunkhwa
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000947 24 linked products · source seen 11 Nov 2026 View source ↗
Corporate profile source ledger Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx24public portfolio records represented
REG24unique registrations represented
IDX24indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR24current validated price records
G8generic molecules in indexed catalogue
DF2dosage-form groups
TA2therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage100%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage79%
priced packs safely normalized per unit
Comparable-market coverage46%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixAshrafsons Pharmaceutical (Pvt) Ltd.Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/ashrafsons-pharmaceutical-pvt-ltdGenerated 11 Nov 2026Fluids & supportive care23 · 96%Anti-infectives1 · 4%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioAshrafsons Pharmaceutical (Pvt) Ltd.Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/ashrafsons-pharmaceutical-pvt-ltdGenerated 11 Nov 202624presentationsInfusion21 · 88%Injection3 · 13%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionAshrafsons Pharmaceutical (Pvt) Ltd.Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/ashrafsons-pharmaceutical-pvt-ltdGenerated 11 Nov 202611comparable productsBelow peer median3 · 27%Near peer median3 · 27%Above peer median5 · 45%Company median price position+2.5%Lowest-price equivalents2Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsAshrafsons Pharmaceutical (Pvt) Ltd.Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/ashrafsons-pharmaceutical-pvt-ltdGenerated 11 Nov 2026Neutro Pharma (Pvt.) Ltd.,7 shared88% overlapMedipak Limited7 shared88% overlapSearle IV Solutions (Pvt) Ltd.7 shared88% overlapUnisa Pharmaceutical Industries Lim…7 shared88% overlapOtsuka Pakistan Limited7 shared88% overlapGALLOP WATER SCIENCES7 shared88% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Formulation footprint

Dosage forms

Infusion21 products
Injection3 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Ashrafsons Pharmaceutical (Pvt) Ltd. is priced against the market

11 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers24Distinct registrations among indexed, published, presentation-validated products only
Verified price observations46
Products with a verified price24
Products with multiple price observations22
Source records with multiple versions24
Latest portfolio source check12 Oct 2026
Latest effective price date28 Sep 2026
Latest source observation11 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

24 unique registration(s) · 24 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Jectmet 100ml Metronidazole 500 mg/100 mL IV infusion 100ml (without Eurocap) 126690 PKR 189.93 PKR 1.90/mL 🔒 Pharma Pro
Jectsol Mannitol 20 % IV infusion 500ml (without Eurocap) 126750 PKR 264.98 PKR 0.53/mL 🔒 Pharma Pro
Jectsol 10ml Water for Injection 10 mL Injection 10ml 114357 PKR 22.08 PKR 2.21/mL 🔒 Pharma Pro
Jectsol 20ml Water for Injection 20 mL Injection 20ml 114358 PKR 29.44 PKR 1.47/mL 🔒 Pharma Pro
Jectsol 5ml Water for Injection 5 mL Injection 5ml 114356 PKR 11.04 PKR 2.21/mL 🔒 Pharma Pro
Jectsol- 1000ml Dextrose Anhydrous 25 % IV infusion 1000ml (without Eurocap) 126751 PKR 193.22 PKR 0.19/mL No comparator
Jectsol- 25ml Dextrose Anhydrous 25 % IV infusion 25ml (without Eurocap) 126807 PKR 34.96 PKR 1.40/mL No comparator
Jectsol-10 1000ml Dextrose 10 g/100 mL IV infusion 1000ml (without Eurocap) 120155 PKR 145.17 PKR 0.15/mL 🔒 Pharma Pro
Jectsol-10 500ml Dextrose 10 g/100 mL IV infusion 500ml (without Eurocap) 120154 PKR 103.51 PKR 0.21/mL 🔒 Pharma Pro
Jectsol-5 1000ml Dextrose + Sodium chloride NaCl 0.45 g + Dextrose 5 g/100 mL IV infusion 1000ml (without Eurocap) 114364 PKR 169.30 PKR 0.17/mL No comparator
Jectsol-5 100ml Dextrose + Sodium chloride NaCl 0.45 g + Dextrose 5 g/100 mL IV infusion 100ml (without Eurocap) 114362 PKR 92.01 PKR 0.92/mL No comparator
Jectsol-5 100ml Dextrose + Sodium chloride NaCl 0.45 g + Dextrose 5 g/100 mL IV infusion 100ml ( with Eurocap) 127801 PKR 68.58 — No comparator
Jectsol-5 500ml Dextrose + Sodium chloride NaCl 0.45 g + Dextrose 5 g/100 mL IV infusion 500ml (without Eurocap) 114363 PKR 139.85 PKR 0.28/mL No comparator
Jectsol-DS 1/2 500ml Dextrose + Sodium chloride NaCl 0.45 g + Dextrose 5.0 g/100 mL IV infusion 500ml without Eurocap) 120127 PKR 95.94 — No comparator
Jectsol-DS 1000ml Dextrose + Sodium chloride NaCl 0.45 g + Dextrose 5 g/100 mL IV infusion 1000ml (without Eurocap) 114366 PKR 178.50 PKR 0.18/mL No comparator
Jectsol-DS 500ml Dextrose + Sodium chloride NaCl 0.45 g + Dextrose 5 g/100 mL IV infusion 500ml (without Eurocap) 114365 PKR 149.05 PKR 0.30/mL No comparator
Jectsol-NS 1000ml Sodium chloride 0.9% w/v IV infusion 1000ml (without Eurocap) 114361 PKR 161.93 PKR 0.16/mL 🔒 Pharma Pro
Jectsol-NS 100ml Sodium chloride 0.9% w/v IV infusion 100ml (without Eurocap) 114359 PKR 92.01 PKR 0.92/mL 🔒 Pharma Pro
Jectsol-NS 100ml Sodium chloride 9 mg/100 mL IV infusion 100ml ( with Eurocap) 127800 PKR 67.45 — No comparator
Jectsol-NS 25ml Sodium chloride 0.9 % IV infusion 25ml (without Eurocap) 126806 PKR 20.24 PKR 0.81/mL 🔒 Pharma Pro
Jectsol-NS 500ml Sodium chloride 0.9% w/v IV infusion 500ml (without Eurocap) 114360 PKR 128.81 PKR 0.26/mL 🔒 Pharma Pro
Jectsol-Peads 500ml Dextrose + Sodium chloride NaCl 0.18 g + Dextrose 4.3 g/100 mL IV infusion 500ml (without Eurocap) 120156 PKR 104.23 PKR 0.21/mL No comparator
Jectsol-RL 1000ml Potassium chloride 0.027 g/100 mL IV infusion 1000ml ( without Eurocap) 117987 PKR 178.50 — No comparator
Jectsol-RL 500ml Potassium chloride 0.027 g/100 mL IV infusion 500ml (PP Bottle without Eurocap) 117986 PKR 143.53 — No comparator
A to Z

All 22 Ashrafsons Pharmaceutical brands in Pakistan

Questions

Ashrafsons Pharmaceutical: common questions

How many products does Ashrafsons Pharmaceutical have in Pakistan?

Ashrafsons Pharmaceutical (Pvt) Ltd has 24 registered medicine presentations in Pakistan, sold under 22 brands and covering 8 generic medicines.

What are the main brands of Ashrafsons Pharmaceutical?

By number of registered strengths and packs, its largest brands are Jectsol-5 100ml (Dextrose + Sodium chloride), Jectsol-NS 100ml (Sodium chloride), Jectmet 100ml (Metronidazole), Jectsol (Mannitol) and Jectsol 10ml (Water for Injection). This is not a sales ranking.

Which therapy areas does Ashrafsons Pharmaceutical cover?

The most products are in Fluids & supportive care (23) and Anti-infectives (1).

Where can I see Ashrafsons Pharmaceutical medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Ashrafsons Pharmaceutical (Pvt) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 11, 2026, from https://medinfobase.com/company/ashrafsons-pharmaceutical-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9